Q2 FY2026 · ended Jun 30, 2026 · Revenue $847,490, +40.0% YoY · Filed Aug 12, 2026
QHSLab, Inc. (USAQ) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $847,490 and net income of $38,030.
Revenue
$847,490
+40.0% vs year-ago quarter
Net income
$38,030
+171.8% vs year-ago quarter
Operating cash flow
$-7,819
-106.2% vs year-ago quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
15.03M
+33.3% vs year-ago quarter
Net cash
$325,211
Q1 FY2026
Operating margin
2.7%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- USAQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Palm Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 856984
- Former names
- USA EQUITIES CORP. (until Apr 19, 2022); AMERICAN BIOGENETIC SCIENCES INC (until Nov 16, 2015)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $847,490 | $728,685 | $703,810 | $737,066 | $605,446 |
| Operating income | $45,245 | -$94,380 | $35,506 | $96,251 | $11,526 |
| Net income | $38,030 | -$103,906 | -$358,261 | $33,411 | -$52,958 |
| Diluted EPS | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 |
| Operating cash flow | -$7,819 | -$200,242 | -$258,203 | $2,601 | $127,033 |
| Total assets | $1.9M | $1.9M | $2.2M | $1.7M | $1.7M |
| Total liabilities | $375,822 | $368,005 | $546,078 | $2.3M | $2.4M |
| Stockholders' equity | $1.6M | $1.5M | $1.6M | -$610,912 | -$644,323 |
| Cash and investments | $317,392 | $362,088 | $636,157 | $158,391 | $168,358 |
| Total debt | — | $36,877 | $90,704 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 26, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 21, 2026 | Apr 21, 2026 |
All 360 QHSLab, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.